Manufacturers: Astellas pharma us inc, Bristol myers squibb co +40 more
Triamcinolone is a glucocorticoid used to treat a wide variety of inflammatory conditions of organ systems and tissues.
Triamcinolone is a glucocorticoid used to treat a wide variety of inflammatory conditions of organ systems and tissues.
Corticosteroids like triamcinolone inhibit phospholipase A2 on cell membranes, preventing the breakdown of lysosomal membranes of leukocytes, which in turn prevent the formation of arachidonic acid, which decrease expression of cyclooxygenase and lipoxygenase, inhibiting synthesis of prostaglandins and leukotrienes. Anti-inflammatory activity occurs via reversal of vascular dilation and reducing permeability, which prevents macrophage and leukocyte migration. Triamcinolone also inhibits nuclear factor kappa-B, which decreases the production of pro-inflammatory signals such as interleukin-6, interleukin-8, and monocyte chemoattractant protein-1.
肾上腺皮质激素类药。主要用于过敏性与自身免疫性炎症性疾病。由于本品潴钠作用较弱，故一般不用作肾上腺皮质功能减退的替代治疗。
110 associated conditions
One entry per invention. Patent families filed in the US, EP, WO and CN offices.
Showing the 100 most relevant patent families.
